retatrutide clinical trial dose results news This is exciting. 👀 The TRIUMPH-4 for Lilly's investigational medication were released, showing weight loss of up to 71 lbs (~28%) over 68 weeks in the highest-dose group—far retatrutide clinical trials efficacy (RETA)

In order for the body to become active and form tyrosine, NALTs acetyl group must be cleaved off or removed

Review Article: Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity Background More than 19 years after the first GLP1RA was introduced for type 2 diabetes and 10 years after its approval for obesity, innovations are expanding the use of GLP-1 medicines for metabolic disorders

Tirzepatide specifically, as a dual GLP-1/GIP agonist, showed more pronounced reductions in LDL, triglycerides, and total cholesterol compared to placebo and SGLT2 inhibitors in a different paper

Theyre also approved for helping to treat serious wounds from trauma or burns